Crinetics Pharmaceuticals
CRNX
CRNX
241 hedge funds and large institutions have $4.46B invested in Crinetics Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 116 increasing their positions, 58 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.34% less ownership
Funds ownership: 117.6% → 117.26% (-0.34%)
14% less capital invested
Capital invested by funds: $5.19B → $4.46B (-$737M)
18% less call options, than puts
Call options by funds: $2.55M | Put options by funds: $3.1M
Holders
241
Holding in Top 10
6
Calls
$2.55M
Puts
$3.1M
Top Buyers
| 1 | +$146M | |
| 2 | +$84M | |
| 3 | +$65.5M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$62.8M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$46.6M |
Top Sellers
| 1 | -$109M | |
| 2 | -$103M | |
| 3 | -$16.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.9M |
